Baxter International Inc. (BAX:NYSE) closed at $25.29 on October 26, 2026, down 0.04% on the day. The stock trades 15.7% below its 52-week high of $30.00 and 60.8% above its 52-week low of $15.73. Over the past year, it gained 9.1%. Baxter International Inc. is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since October 24, 2025, BAX closed higher on 125 days (50%). Its best day was July 30, 2026 (+7.99%) and its worst was February 12, 2026 (-15.99%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 1 time.
Baxter International Inc. provides a portfolio of renal and hospital products. The company operates through two segments, Hospital Products and Renal. The Hospital Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies. This segment offers products for various treatment continuums, such as technologies and therapies for peritoneal dialysis, hemodialysis, continuous renal replacement therapy, and additional dialysis services. The company sells its products for use in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. It offers its products through direct sales force, independent distributors, drug...
Find more stocks like BAX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.